Magnetic Testis Targeting and Magnetic Hyperthermia for Noninvasive, Controllable Male Contraception via Intravenous Administration

Nano Lett. 2021 Jul 28;21(14):6289-6297. doi: 10.1021/acs.nanolett.1c02181. Epub 2021 Jul 7.

Abstract

Mild testicular hyperthermia by the photothermal effect of gold nanorods could realize controllable male contraception. However, associated limitations, such as testicular administration and infrared laser inflicting severe pain, and the nondegradability of nanoparticles potentially causing toxicity, have restricted further clinical application. Inspired by the excellent physicochemical properties of iron oxide nanoparticles (IONPs), and the finding that testicular injection of PEG-coated IONPs with a diameter of 50 nm (PEG@Fe3O4-50) following an alternating magnetic field (AMF) could achieve controllable male contraception; here we propose a noninvasive, targeting approach for male contraception via intravenous administration. The magnetic properties and testes targeting of IONPs were proven to be greatly affected by their surface chemistry and particle size. After systemic administration, citric acid stabilized IONPs with size of 100 nm (CA@Fe3O4-100) were found to be the best ideal thermoagent for realizing the noninvasive contraception. This study offers new strategies for male contraception.

Keywords: iron oxide nanoparticles; magnetic properties; male contraception; noninvasive; testes targeting.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Intravenous
  • Contraception
  • Humans
  • Hyperthermia
  • Hyperthermia, Induced*
  • Magnetic Fields
  • Magnetite Nanoparticles*
  • Male
  • Testis

Substances

  • Magnetite Nanoparticles